{
    "Trade/Device Name(s)": [
        "Audit\u00ae MicroLQ\u2122 Spinal Fluid",
        "AUDIT\u00ae MicroLQT Spinal Fluid Control Set"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K112742",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101216"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "April 23, 2012",
    "Summary Letter Received Date": "April 25, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Chloride",
        "Glucose",
        "Immunoglobulin A (IgA)",
        "Immunoglobulin G (IgG)",
        "Immunoglobulin M (IgM)",
        "Lactate",
        "Lactate Dehydrogenase (LD)",
        "Microalbumin",
        "Microprotein",
        "Sodium"
    ],
    "Specimen Type(s)": [
        "Spinal Fluid"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Quality control material"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Quality control material",
        "Set"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u00ae MicroLQ\u2122 Spinal Fluid quality control material for monitoring precision in spinal fluid laboratory assays",
    "Indications for Use Summary": "Intended for monitoring the precision of laboratory testing procedures as an in vitro diagnostic quality control material",
    "fda_folder": "Clinical Chemistry"
}